1 tracked superinvestor hold Dbv Technologies S A Sponsored (DBVT), worth $6M combined, led by Stanley Druckenmiller. Smart money is holding DBVT as of the latest 13F filings.
Current price
$13.47
+46.1%
1Y
DBV Technologies S.A., a biopharmaceutical firm based in Montrouge, France, operates at the clinical stage, focusing on the research and development of epicutaneous immunotherapy solutions. Its flagship product, Viaskin Peanut, has completed Phase III clinical trials as an immunotherapy for peanut allergies in children aged 4 to 11, adolescents, and adults. The company's pipeline also includes…
Market cap
$475M
P/E
-3.78
Div yield
0.0%
Revenue YoY
0.0%
Analyst target
$46
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
1
tracked 13F / N-PORT funds
Combined value
$6M
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
0
0 buying · 0 selling
Smart money is holding DBVT steady this quarter — buys and sells are balanced.
Dbv Technologies S A Sponsored (DBVT) is held by 1 tracked funds worth $6M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to Stanley Druckenmiller at 0.1% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
Tracked holders were largely static this quarter — no new opens, adds or trims of size — suggesting the position is being held rather than actively traded.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Held | 0.1% | $6M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own DBVT?
1 tracked funds hold Dbv Technologies S A Sponsored (DBVT), the largest being Stanley Druckenmiller (Duquesne Family Office) at 0.1% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling DBVT?
In the most recent 13F quarter, 0 tracked funds added or opened DBVT and 0 trimmed it.
How much DBVT do tracked funds hold?
Combined disclosed long exposure to DBVT across tracked superinvestors is $6M as of the Jun 2026 filings.
One email when a tracked manager opens, adds to or files to sell a position — from Form 4, 13D and Form 144, not the 45-day-old 13F.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Jun 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.